The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana. - Wikidata - wikimedia - TriplyDB

The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana.

The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana.

http://www.wikidata.org/entity/Q45014102

about

A pool of repeat blood donors can be generated with little expense to the blood center in sub-Saharan Africa.Prevalence of hepatitis B and C virus infections among patients with chronic hepatitis at Bereka Medical Center, Southeast Ethiopia: a retrospective study Simultaneous visual detection of multiple viral amplicons by dipstick assay.Hepatitis B and C viral infections among blood donors. A retrospective study from a rural community of Ghana.Detection of highly prevalent hepatitis B virus coinfection among HIV-seropositive persons in Ghana.Prevalence of hepatitis B virus infection among blood donors at the Tamale Teaching Hospital, Ghana (2009).Hepatitis B virus (HBV) infection and recombination between HBV genotypes D and E in asymptomatic blood donors from Khartoum, Sudan Hepatitis B virus infection does not significantly influence Plasmodium parasite density in asymptomatic infections in Ghanaian transfusion recipients.Sero-prevalence and factors associated with Hepatitis B and C co-infection in pregnant Nigerian women living with HIV infection.Risk factors associated with hepatitis B exposure and the reliability of five rapid kits commonly used for screening blood donors in Ghana.Hospital-based surveillance for viral hemorrhagic fevers and hepatitides in Ghana.Automated nucleic acid amplification testing in blood banks: An additional layer of blood safety.HBsAg seroprevalence among Senegalese militaries.Reducing the risk of hepatitis B virus transfusion-transmitted infection Diagnostic accuracy of blood centers in the screening of blood donors for viral markers.Occult hepatitis B virus infection: implications in transfusion.Hepatitis B and C viral infections among blood donors from rural Ghana Improving blood safety in resource-poor settings.Viral hepatitis among Somali immigrants in Minnesota: association of hepatitis C with hepatocellular carcinoma.Hepatitis B in Ghana: a systematic review & meta-analysis of prevalence studies (1995-2015)Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safety Recent developments in the diagnosis and monitoring of HBV infection and role of the genetic variability of the S gene.Significance of Response to Hepatitis B Recombinant Vaccine in Subjects with Isolated Antibody to Hepatitis B Core Antigen New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods.Hepatitis B virus blood screening: unfinished agendas.Occult hepatitis B virus infection among Egyptian blood donors.Viral hepatitis in resource-limited countries and access to antiviral therapies: current and future challenges.Evaluation of a new hepatitis B virus surface antigen rapid test with improved sensitivity.Highly sensitive detection of hepatitis B virus surface antigen by use of a semiautomated immune complex transfer chemiluminescence enzyme immunoassay.Characteristics of hepatitis B infection in a sample of omani patients.Prevalence and characterization of occult hepatitis B infection among blood donors in central Saudi Arabia Identification and characterization of persistent human erythrovirus infection in blood donor samples.Aflatoxin B1 inhibits the type 1 interferon response pathway via STAT1 suggesting another mechanism of hepatocellular carcinoma Moving on from voluntary non-remunerated donors: who is the best blood donor?Hepatitis B virus infection in children.Screening and diagnosis of HBV in low-income and middle-income countries.Full genome characterization of hepatitis B virus strains from blood donors in Iran.Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes.Molecular characterization of hepatitis B virus in blood donors from Burkina Faso: Prevalence of quasi-subgenotype A3, genotype E, and mixed infections.Hepatitis B virus surface antigen and anti-hepatitis C virus rapid tests underestimate hepatitis prevalence among HIV-infected patients.

P2860

Q30367139-A3DF2968-FA2F-4E7C-B335-4B1C21E25FED Q33655299-74999D0A-9A08-4919-A6EC-3DF48CA88E7E Q34041871-F817D8C1-BE7D-4487-83FF-68D834130DE6 Q34094931-C68E8C56-8F16-4F74-89B4-13B62B921730 Q34120399-578F896D-0A21-4EA4-9E4C-B30FB40C5242 Q34167101-90DEC38A-5090-4C25-B2EA-A2A1E6518FC5 Q34487699-479E4340-6827-4E81-AF93-2D8D527E99E5 Q34490797-5BB6FF04-A48C-4D71-AB99-B16C7ED8B13B Q34496866-604EAC33-4618-49FC-890B-830D185A8D3F Q34969698-73E0EB8F-BD54-447B-B865-6DD1ADF4C307 Q34999873-66765910-D1C6-44D5-9559-2CB31220629B Q35119946-9D002DE5-188E-4C49-B6A9-AA0216D34A49 Q35633801-7D63BF18-113F-4C91-8EA2-68449447BE9B Q35683881-7C074C6E-B2E3-4E34-99DF-D6BB439E2D76 Q35690827-A3A2E1B8-B979-4028-ABF6-5BB636C0176C Q35691937-808A032A-1698-42AD-8785-6FB755F59EF6 Q35694840-7DC53063-91D3-47A1-8D6D-9A8DC640A3AF Q35813057-03520D90-9E35-43BE-832F-96557DAA932D Q35916158-F5F76A7C-A976-44FB-BE70-3075B9794985 Q35961475-A05DF1C1-1CDA-41E9-B660-250E0AB36501 Q36034896-FA3E3DD0-5BEF-440C-9A10-3628DD6A4A61 Q36050544-744622A5-145E-46C6-A41B-4BE4D3A7E20E Q36306899-6C870DE3-850F-4A4F-8510-006FFA0DCF00 Q36466447-E5F4FC41-387F-452F-B729-A1BC32053CEC Q36498410-44861F1E-1BA9-484B-98A9-B4855C6545E2 Q36812851-B2C669E4-C618-4433-B574-C73C1BC81029 Q36821936-C158A7CE-D0B1-41FE-B3C9-332C0680AE44 Q36933452-06A67EF0-28B8-4E80-9ED6-98A31BBEE153 Q36971054-6A2D4E35-7ED8-48B6-868F-05731915F001 Q37109576-293D9A77-EBBD-4A7B-8935-6A3CA0BAFED5 Q37359249-A5F22F23-624A-4BCD-ADE8-0771FCC1125D Q37596753-993B7B2D-407E-48CC-A550-03AB09EB2B37 Q37713659-4F989B9C-1839-4676-B9F6-12EC99CB8974 Q37871619-A3E6D3DC-9094-49B3-8684-9DCEC02207A8 Q38365905-694F1CB5-39A6-4B91-AE5D-E4CF24F97927 Q38953790-C39778BE-99CD-4565-8F1C-30159806F024 Q39018089-65F5AFC6-11BF-4D1D-AD0E-ED80E0BDD9DF Q39147501-CC02CBBF-9A06-4E4B-8FB1-E2CBE4DCA584 Q40648759-A0B1DBE4-6865-46D7-9F8E-3D513B2527E6 Q42220089-A0587F8D-5E93-45EE-BF97-469FF981134E

P2860

The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana.

http://www.wikidata.org/entity/Q45014102

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh

2002年學術文章

@zh-hant

name

The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana.

@en

The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana.

@nl

type

label

The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana.

@en

The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana.

@nl

prefLabel

The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana.

@en

The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana.

@nl

P1433

Q45014102-AE8DD6CE-8DAF-49B5-98E1-56C6FF74E784

P1476

Q45014102-49334251-864A-41AC-ADB0-6001773FFA85

P2093

Q45014102-023581AC-26E8-4346-8F8E-FD9829C31BE0

Q45014102-0A06B1EC-F975-422B-9404-D67CCAEE0A88

Q45014102-1B11C230-75F6-4862-B2A6-C481B5DEF04E

Q45014102-1CC180C9-CA4C-4881-AA77-B76DCD00A4CE

Q45014102-35AFD592-7ED6-4484-826E-F1DFEE7D267E

Q45014102-5AB648B0-2F71-4C79-9A1D-905F481114AC

Q45014102-67FC5E6F-2629-49D2-98C3-CE0D241D97F5

Q45014102-68FF786C-4C1A-48B4-9EB7-894F85BA4F93

Q45014102-950E1B32-D75B-4E6F-8586-59BC47EEF153

Q45014102-A4AF087F-EE59-47E8-8198-E4A50139E2AE

P304

Q45014102-DCAB2931-1802-47F8-B3DD-826E25565FF0

P31

Q45014102-7A9CB11A-A5B1-4E3B-A71B-61FB773B0405

P356

Q45014102-F9228851-9134-4FF0-A308-E622B8DDECE1

P407

Q45014102-9A03F5C4-908F-45C1-88B5-FF01BA799166

P433

Q45014102-C724589D-AE28-401E-ADC5-AC59FB5CC56C

P478

Q45014102-952EB14B-9A00-4A55-8795-927D93832441

P577

Q45014102-07536DD0-3ED2-4E0C-97B6-69AC2BAFD6E9

P5875

Q45014102-365C8DFB-1980-4F7E-80A8-6742B977E972

P698

Q45014102-8B81A86F-A19C-4E49-BFE2-A21FEA1A955E

P921

Q45014102-A298098D-8E80-4288-9CA3-350A4A354881

P356

BLOOD-2002-04-1084

P1433

P1476

The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana.

@en

P2093

Bruce Phelps

http://www.w3.org/2001/XMLSchema#string

Cristina Giachetti

http://www.w3.org/2001/XMLSchema#string

Daniel Candotti

http://www.w3.org/2001/XMLSchema#string

Francis Sarkodie

http://www.w3.org/2001/XMLSchema#string

Francis Yeboah

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre Allain

http://www.w3.org/2001/XMLSchema#string

Kate Soldan

http://www.w3.org/2001/XMLSchema#string

Margaret Anokwa

http://www.w3.org/2001/XMLSchema#string

Ohene Opare-Sem

http://www.w3.org/2001/XMLSchema#string

Shirley Owusu-Ofori

http://www.w3.org/2001/XMLSchema#string

P304

2419-2425

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2002-04-1084

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P577

2002-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11068654

http://www.w3.org/2001/XMLSchema#string

P698

12393691

http://www.w3.org/2001/XMLSchema#string

P921